Jump to ContentJump to Main Navigation
Venous Thromboembolism in Advanced DiseaseA clinical guide$
Users without a subscription are not able to see the full content.

Simon I R Noble, Miriam J Johnson, and Agnes Y Y Lee

Print publication date: 2008

Print ISBN-13: 9780199232048

Published to Oxford Scholarship Online: November 2011

DOI: 10.1093/acprof:oso/9780199232048.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 22 September 2021

Anticoagulants: current and future therapeutic options

Anticoagulants: current and future therapeutic options

(p.65) Chapter 5 Anticoagulants: current and future therapeutic options
Venous Thromboembolism in Advanced Disease

Robert Weinkove

Beverley J. Hunt

Oxford University Press

This chapter aims to review the pharmacology and use of both the established and the newer anticoagulants used in venous thromboembolism (VTE). These include unfractionated heparin, low molecular weight heparins (LMWH), danaparoid, coumarins, idraparinux, and hirudin. This chapter discusses the history, composition, mechanism of action, dosage, monitoring, reversal, indications and contraindications, and adverse effects of these anticoagulants.

Keywords:   anticoagulants, VTE, unfractionated heparin, low molecular weight herapins, danaparoid, idraparinux, hirudin

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .